The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Oncogenes can alter cellular growth factor requirements, leading to transformation.
• Tyrosine protein kinase oncogenes, such as trk, are known to affect hematopoietic cell growth factor dependency.
• Interleukin-3 (IL-3) is a critical growth factor for hematopoietic cells.

Purpose of the Study:

• To investigate the effect of the human trk oncogene on hematopoietic cell growth factor requirements.
• To elucidate the mechanism by which the trk oncogene abrogates growth factor dependency.
• To identify downstream signaling events affected by trk oncogene expression in hematopoietic cells.

Main Methods:

• Utilized a replication-defective murine retrovirus to express the human trk oncogene in hematopoietic cells.
• Assessed growth factor requirements of trk-transformed hematopoietic cells.
• Analyzed protein phosphorylation patterns on tyrosine residues in response to IL-3 stimulation using Western blotting or similar techniques.

Main Results:

• The human trk oncogene abrogated the growth factor requirements of hematopoietic cells via a non-autocrine mechanism.
• Many cellular proteins exhibited constitutive tyrosine phosphorylation in trk-transformed cells, independent of IL-3.
• A 140 kDa membrane IL-3-binding protein remained dependent on IL-3 for phosphorylation, unlike other tyrosine-phosphorylated proteins.

Conclusions:

• The trk oncogene confers IL-3 independence to hematopoietic cells by altering signaling pathways.
• Constitutive activation of tyrosine kinase activity by the trk oncogene bypasses the need for IL-3 signaling for proliferation.
• The differential phosphorylation of the 140 kDa IL-3-binding protein suggests a specific role in mediating IL-3-dependent signaling that is not fully bypassed by trk.